Мometasone furoate/formoterol: new fixed-dose combination in the treatment of bronchial asthma
https://doi.org/10.21518/2079-701X-2013-11-20-25
Abstract
The medical and social significance of bronchial asthma (BA) is explained by its high incidence (5-10%), dramatic decline in the quality of life of patients and high cost of treatment. Severe exacerbations of asthma may cause death at any age. Studies carried out in different countries of the world revealed inadequate asthma control in clinical practice [1, 2]. For example, in 56% of Russian patients who seek medica aid of specialists and GPs the disease is not controlled [3]. The treatment of asthma needs to improved.
About the Author
A. V. Еmelyanov
Northwestern State Medical University named after I.I. Mechnikov, St. Petersburg
Russian Federation
Russian Federation
References
1. Rabe K.F., Vermeire P.A., Soriano J.B., Maier W.C. // Eur. Respir. J. 2000. №16. Р. 802–807.
2. Partridge M.R., van der Molen T., Myrseth S.E., Busse W.W. // BMC. Pulm. Med. 2006. №6. Р. 13.
3. Емельянов А.В., Горячкина Л.А., Астафьева Н.Г. и соавт. Аллергический ринит и бронхиаль-ная астма в реальной клинической практике: результаты Российского многоцентрового исследования // Российский аллергологический журнал. 2012. №1. C. 29–33.
4. Sharpe M., Jarvis B. Inhaled mometasone furoate. A review of its use in adults and adolescents with persistent asthma // Drugs. 2001. №61. Р. 1325–1350.
5. Chapman R.W., Sehring S.L., Gallisi C.G. et al. Anti-inflammatory activity of inhaled mometasone furoate in allergic mice // Arzneimittel Forshung. 1998. №48. Р. 384–391.
6. Barnes P. Optimizing the anti-inflammatory effects of corticosteroids // Eur. Respir. Rev. 2001. №11. Р. 15–22.
7. Bartow R.A., Brogden R.N. Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma // Drugs. 1998. №55 (2). Р. 303–322.
8. Frampton J.E. Mometasone/Formoterol Inhalation Aerosol In Asthma Uncontrolled on Medium- or High-Dose Inhaled Corticosteroids // Drugs. 2012. №72(9). Р. 1229–1241.
9. Nolte H., Pavord I., Backer V. et al. Dose-dependent anti-inflammatory effect of inhaled mome-tasone furoate/formoterol in subjects with asthma // Respir. Med. 2013. Mar. 9. pii: S0954-6111(13)00059-0 [E-pub ahead print]
10. Berger W.E. Mometasone furoate/formoterol in the treatment of persistent asthma // Expert Rev. Respir. Med. 2011. №5(6). Р. 739–746.
11. Affrime M.B., Cuss F., Padhi D. et al. Bioavailability and metabolism of mometasone furoate fol-lowing administration by metered- dose and dry- powder inhalers in healthy volunteers // J. Clin. Pharm. 2000. V. 40. Р. 1227–1236.
12. Affrime M.B., Kosoglou T. The pharmacokinetics of mometasone furoate administered by dry pow-der inhaler following single and multiple dosing in patients with mild and moderate persistent asthma // J. Allergy Clin. Immunol. 2001. V. 107. Р. S104.
13. Padden J., Skoner D. and Hochhaus G. Pharmacokinetics and pharmacodynamics of inhaled gluco-corticoids // Journal of Asthma. 2008. №45 (Suppl. 1). Р. 13–24.
14. Meltzer E.O., Kuna P., Nolte H. et al. Mometasone furoate/ formoterol reduces asthma deteriorations and improves lung function // Eur. Respir. J. Epub. 2011. Aug. 4.
15. Nathan R.A., Nolte H., Pearlman D.S. Twenty-six-week efficacy and safety study of mometasone furoate/formoterol 200/10 mg combination treatment in patients with persistent asthma previously receiving medium-dose inhaled cortico- steroids // Allergy Asthma Proc. 2010. №31 (4). Р. 269–279.
16. Weinstein S.F., Corren J., Murphy K. et al. Twelve-week efficacy and safety study of mometasone furoate/formoterol 200/10 mg and 400/10 mg combination treatments in patients with persistent asthma pre-viously receiving high-dose inhaled corticosteroids // Allergy Asthma Proc. 2010. №31 (4). Р. 280–289.
17. Bernstein D., Hébert J., Cheema A. et al. Efficacy and onset of action of mometasone fu-roate/formoterol and fluticasone propionate/ salmeterol combination treatment in subjects with persistent asthma // Allergy, Asthma & Clinical Immunology. 2011. №7. Р. 21.
18. Maspero J.F., Nolte H., Cherrez-Ojeda I. et al. Long-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthma // J. Asthma. 2010. №47. Р. 1106–1115.
19. Westergaard C., Porsbjerg C., Backer V. A review of mometasone furoate / formoterol in the treat-ment of asthmа // Expert Opinion on Pharmacotherapy. 2013. №14 (3). Р. 339–346.20.
20. Зенхейл. Инструкция по медицинскому применению, 2012.
21. Weinstein C., Staudinger H., Scott I. et al. Dose counter performance of mometasone fu-roate/formoterol inhalers in subjects with asthma or COPD // Respir. Med. 2011. №105. Р. 979–988.
Review
For citations:
Еmelyanov AV. Мometasone furoate/formoterol: new fixed-dose combination in the treatment of bronchial asthma. Meditsinskiy sovet = Medical Council. 2013;(11):20-25. (In Russ.) https://doi.org/10.21518/2079-701X-2013-11-20-25
Views:
930
Email this article 